Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA)

CUSIP: 45826J105

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
116,932,531
Total 13F shares
99,191,549
Share change
+2,519,023
Total reported value
$1,156,525,724
Put/Call ratio
79%
Price per share
$11.66
Number of holders
288
Value change
-$49,302,844
Number of buys
164
Number of sells
115

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q4 2024

As of 31 Dec 2024, Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by 288 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 99,191,549 shares. The largest 10 holders included ARK Investment Management LLC, BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, REGENERON PHARMACEUTICALS, INC., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Group, Inc., CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 289 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.